Nausea, diarrhea, and constipation affect significant percentages of users during dose escalation
For example, the SURMOUNT-1 program found that 5 mg weekly resulted in meaningful weight loss compared with the placebo, while higher doses produced larger effects
We've seen compelling data, extending into early 2026, demonstrating substantial reductions in body weight in various research models, often surpassing what's observed with other pharmacological interventions aimed at appetite control
Hitting both incretin pathways at once is the structural reason tirzepatide produces larger weight effects than semaglutide in head-to-head trial comparisons
A pill containing 25 mg of semaglutide delivers results comparable to Novo Nordisks 2.4 mg injectable, according to the press release
Dispelling Myths About Lipotropic Injections Myth: Lipotropic injections are only for weight loss